2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow CAN1012: new trials by email Literature Review of CAN1012 trials Research Report on CAN1012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAN1012 Combined With PD-1 in Patients With Solid Tumors CAN1012 - Advanced Solid Tumor | Phase 1 / Phase 2 | Unknown | Canwell Biotech Limited | 71 | 2024-06-27 | 2024-10-31 |
| Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors CAN1012 - Solid Tumor, Cancer Metastatic | Phase 1 | Unknown | CanWell Pharma Inc. | 36 | 2022-01-20 | 2023-12-22 |
CanWell Pharma Inc. (1) · Canwell Biotech Limited (1)
China (1) · United States (1)